Clinical Trial Update: VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing VTX958 to placebo for active Psoriatic arthritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• VTX958

Snippet

Sponsor: Ventyx Biosciences, Inc | Conditions: Psoriatic Arthritis | Phase 2 | Status: TERMINATED